ArticleJournal for immunotherapy of cancer2020

Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancer.

Peixin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.